Myocardial Revascularization Strategies in Diabetic Patients with Multi-Vessel Disease: CABG vs DES-Based PCI

Author(s): George Kassimis, Niket Patel, Adrian P. Banning

Journal Name: Current Pharmaceutical Design

Volume 20 , Issue 28 , 2014

Become EABM
Become Reviewer
Call for Editor


Randomized trials comparing multi-vessel percutaneous coronary intervention to coronary artery bypass grafting (CABG) have demonstrated the long-term superiority of CABG in diabetic patients. Benefits include improved survival, fewer recurrent myocardial infarctions and a lower risk of the need for repeat intervention. The focus of this review article is to review the contemporary management of diabetic patients with multi-vessel coronary artery disease.

Keywords: Percutaneous coronary intervention, Drug eluting stents, Coronary artery bypass grafting, Diabetes mellitus, Coronary artery disease, Revascularization, Survival.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2014
Page: [4589 - 4596]
Pages: 8
DOI: 10.2174/1381612820666140225094157
Price: $65

Article Metrics

PDF: 21